These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29651431)

  • 21. P-Glycoprotein-mediated resistance to Hsp90-directed therapy is eclipsed by the heat shock response.
    McCollum AK; TenEyck CJ; Stensgard B; Morlan BW; Ballman KV; Jenkins RB; Toft DO; Erlichman C
    Cancer Res; 2008 Sep; 68(18):7419-27. PubMed ID: 18794130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of heat-shock protein (HSP) 90 expression in acute myeloid leukemia cells.
    Flandrin P; Guyotat D; Duval A; Cornillon J; Tavernier E; Nadal N; Campos L
    Cell Stress Chaperones; 2008 Sep; 13(3):357-64. PubMed ID: 18386162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Hsp90 inhibitor 17-allylamide-17-demethoxygeldanamycin induces apoptosis and differentiation of Kasumi-1 harboring the Asn822Lys KIT mutation and down-regulates KIT protein level.
    Yu W; Rao Q; Wang M; Tian Z; Lin D; Liu X; Wang J
    Leuk Res; 2006 May; 30(5):575-82. PubMed ID: 16213582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat shock protein 90 inhibition depletes TrkA levels and signaling in human acute leukemia cells.
    Rao R; Nalluri S; Fiskus W; Balusu R; Joshi A; Mudunuru U; Buckley KM; Robbins K; Ustun C; Reuther GW; Bhalla KN
    Mol Cancer Ther; 2010 Aug; 9(8):2232-42. PubMed ID: 20663926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
    Dello Russo C; Polak PE; Mercado PR; Spagnolo A; Sharp A; Murphy P; Kamal A; Burrows FJ; Fritz LC; Feinstein DL
    J Neurochem; 2006 Dec; 99(5):1351-62. PubMed ID: 17064348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors.
    van der Kraan AG; Chai RC; Singh PP; Lang BJ; Xu J; Gillespie MT; Price JT; Quinn JM
    Biochem J; 2013 Apr; 451(2):235-44. PubMed ID: 23379601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Major Heat Shock Proteins, Hsp70 and Hsp90, in 2-Methoxyestradiol-Mediated Osteosarcoma Cell Death Model.
    Gorska-Ponikowska M; Kuban-Jankowska A; Marino Gammazza A; Daca A; Wierzbicka JM; Zmijewski MA; Luu HH; Wozniak M; Cappello F
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
    Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
    Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor beta-activated kinase 1 (TAK1) in interleukin-1beta-induced cell signaling.
    Shi L; Zhang Z; Fang S; Xu J; Liu J; Shen J; Fang F; Luo L; Yin Z
    Mol Immunol; 2009 Feb; 46(4):541-50. PubMed ID: 18950863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cells.
    Rao R; Fiskus W; Yang Y; Lee P; Joshi R; Fernandez P; Mandawat A; Atadja P; Bradner JE; Bhalla K
    Blood; 2008 Sep; 112(5):1886-93. PubMed ID: 18591380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of multiple heat shock proteins and neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis.
    Batulan Z; Taylor DM; Aarons RJ; Minotti S; Doroudchi MM; Nalbantoglu J; Durham HD
    Neurobiol Dis; 2006 Nov; 24(2):213-25. PubMed ID: 16950627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heat shock protein 90 inhibitor induces apoptosis and attenuates activation of hepatic stellate cells.
    Myung SJ; Yoon JH; Kim BH; Lee JH; Jung EU; Lee HS
    J Pharmacol Exp Ther; 2009 Jul; 330(1):276-82. PubMed ID: 19329756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heat shock protein 90 interacts with vitamin D receptor in human leukemia cells.
    Marcinkowska E; Gocek E
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):114-6. PubMed ID: 20138989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heat shock protein 90 inhibitors suppress pyroptosis in THP-1 cells.
    Zhou Z; Li X; Qian Y; Liu C; Huang X; Fu M
    Biochem J; 2020 Oct; 477(20):3923-3934. PubMed ID: 32497199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition.
    Hertlein E; Wagner AJ; Jones J; Lin TS; Maddocks KJ; Towns WH; Goettl VM; Zhang X; Jarjoura D; Raymond CA; West DA; Croce CM; Byrd JC; Johnson AJ
    Blood; 2010 Jul; 116(1):45-53. PubMed ID: 20351313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HSP90 inhibition suppresses inflammatory response and reduces carotid atherosclerotic plaque formation in ApoE mice.
    Mu H; Wang L; Zhao L
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28009484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activation.
    Broemer M; Krappmann D; Scheidereit C
    Oncogene; 2004 Jul; 23(31):5378-86. PubMed ID: 15077173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HSP90 inhibition by 17-DMAG reduces inflammation in J774 macrophages through suppression of Akt and nuclear factor-κB pathways.
    Shimp SK; Parson CD; Regna NL; Thomas AN; Chafin CB; Reilly CM; Nichole Rylander M
    Inflamm Res; 2012 May; 61(5):521-33. PubMed ID: 22327510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of heat shock protein HSPA6 (HSP70B') upon HSP90 inhibition in cancer cell lines.
    Kuballa P; Baumann AL; Mayer K; Bär U; Burtscher H; Brinkmann U
    FEBS Lett; 2015 Jun; 589(13):1450-8. PubMed ID: 25957766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells.
    Schumacher JA; Crockett DK; Elenitoba-Johnson KS; Lim MS
    Proteomics; 2007 Aug; 7(15):2603-16. PubMed ID: 17610208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.